advertisement

Topcon

Rowe-Rendleman CL 1

Showing records 1 to 1 | Display all abstracts from Rowe-Rendleman CL

65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Suto F; Rowe-Rendleman CL; Ouchi T; Jamil A; Wood A; Ward CL
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970

Issue 17-3

Change Issue


advertisement

Oculus